<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="71154">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02179476</url>
  </required_header>
  <id_info>
    <org_study_id>DUET 001-003</org_study_id>
    <nct_id>NCT02179476</nct_id>
  </id_info>
  <brief_title>A Multi-Site Study of the Zyga GlyDer Facet Restoration Device In Subjects With LUmbar FacET Pain Syndrome - DUET</brief_title>
  <acronym>DUET</acronym>
  <official_title>A Multi-Site Study of the Zyga GlyDer Facet Restoration Device In Subjects With LUmbar FacET Pain Syndrome (DUET)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zyga Technology, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zyga Technology, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A non-randomized, multi-site feasibility study to evaluate the safety of the Glyder Device
      in subjects with a history of lumbar facet joint disease (L2 to the sacrum) and successful
      neural ablation in which the facet joint is confirmed as the source of pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Safety Endpoint</measure>
    <time_frame>6 months</time_frame>
    <description>Safety will be evaluated by assessing the incidence of device and/or procedure related serious adverse events.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Facet Joint Pain</condition>
  <arm_group>
    <arm_group_label>Glyder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Glyder Facet Restoration Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Glyder</intervention_name>
    <description>The Glyder Facet Restoration Device is intended for minimally invasive bilateral implantation in one or two lumbar facet levels</description>
    <arm_group_label>Glyder</arm_group_label>
    <other_name>Glyder Facet Restoration Device</other_name>
    <other_name>Glyder Device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          1. Confirmed bilateral facet joint disease demonstrated by a successful facet rhizotomy
             (neural ablation) within 18 months prior to enrollment

          2. Facet pain is limited to one to two levels from L2 to the sacrum and pain is
             bilateral

          3. Two diagnostic injections (MBBs) both resulting in 80% relief to confirm back pain is
             facetogenic

          4. VAS back pain of ≥ 60 mm on a 100 mm scale, and VAS back pain is greater than or
             equal to the highest VAS leg pain score

          5. ODI ≥ 20 points

          6. At least six (6) months of non-operative conservative management (Analgesic therapy
             for a minimum of 2 weeks and a minimum of 4 weeks of NSAID therapy; Supervised
             exercise and/or physical therapy program-minimum of 12 sessions)

          7. At least 22 years of age and skeletally mature

        Key Exclusion Criteria:

          1. Pain is from a spinal structure other than facet joints (i.e., disc, hip and SI joint
             pain are excluded)

          2. Osteoporosis or severe osteopenia

          3. Lumbar fusion

          4. Symptomatic spinal stenosis requiring surgical intervention

          5. Prior total disc replacement, fusion, decompressive laminectomy, facetectomy, or
             placement of a posterior spinous process device

          6. Disc herniation requiring surgical intervention

          7. The subject has a Body Mass Index (BMI) of greater than 35

          8. Planned elective surgery within 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lisa Ingham</last_name>
    <phone>952-698-9958</phone>
    <email>lingham@zyga.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Spine Institute</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lacey Feldman</last_name>
      <phone>310-828-7757</phone>
      <email>lacey.feldman@cshs.org</email>
    </contact>
    <contact_backup>
      <last_name>Luc Fortier</last_name>
      <phone>310-828-7757</phone>
      <email>Luc.Fortier@cshs.org</email>
    </contact_backup>
    <investigator>
      <last_name>Hyun Bae, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laser Spine Institute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Davis</last_name>
      <phone>866-362-7574</phone>
      <phone_ext>154</phone_ext>
      <email>rdavis3@laserspineinstitute.com</email>
    </contact>
    <contact_backup>
      <last_name>Kevin Farquharson, MD</last_name>
      <phone>866-362-7574</phone>
      <phone_ext>838</phone_ext>
      <email>kfarquharson2@laserspineinstitute.com</email>
    </contact_backup>
    <investigator>
      <last_name>Reginald Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greater Baltimore Neurological Associates</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Radiology of Oklahoma</name>
      <address>
        <city>Edmond</city>
        <state>Oklahoma</state>
        <zip>73083</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Witherby</last_name>
      <phone>405-601-2325</phone>
      <email>jw@clinrad.org</email>
    </contact>
    <investigator>
      <last_name>Douglas Beall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwest Orthopaedic Specialists</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mirna Tohmeh</last_name>
      <email>tohmeh@comcast.net</email>
    </contact>
    <investigator>
      <last_name>Antoine Tohmeh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 8, 2016</lastchanged_date>
  <firstreceived_date>January 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Facet joint</keyword>
  <keyword>facet joint pain</keyword>
  <keyword>facet joint disease</keyword>
  <keyword>lumbar pain</keyword>
  <keyword>back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthralgia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
